Knowledge (XXG)

Oxygen diffusion-enhancing compound

Source 📝

84:(TSC), a synthetic drug containing the carotenoid structure of trans crocetin has been extensively investigated in animal disease models and in human clinical trials. Clinical trials of TSC have focused on testing the compound's effectiveness in sensitizing hypoxic cancer cells to radiation therapy in patients with 131:
among water molecules, which constitute the majority of the blood plasma medium. As hydrogen bonding increases, the overall molecular structure of water in the plasma becomes more lattice-like, a phenomenon known as structure building. Structure building reduces resistance to the movement of oxygen
166: 440: 408: 300:
Lapchak P (2010). "Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: A combination therapy study with tissue plasminogen activator".
95:, has been shown to enhance the oxygenation of hypoxic tumor tissue and belongs to a subclass of oxygen diffusion-enhancing compounds known as bipolar trans carotenoid salts. 484: 348:"Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)" 457:
Laidig, K.E., J.L. Gainer, V. Daggett (1998). "Altering Diffusivity in Biological Solutions through Modification of Solution Structure and Dynamics".
136:
and into the tissues, the more structured character of water imparted by the oxygen diffusion-enhancing compound will enhance movement into tissues.
265:
Abdullaev F, Espinosa-Aguirre J (2004). "Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials".
626: 584: 510: 139:
Computer simulations have shown that TSC specifically can increase the transport of oxygen through water by as much as 30 percent.
36:) of oxygen through plasma. Oxygen diffusion-enhancing compounds have shown promise in the treatment of conditions associated with 409:"Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS" 373:
Sheehan, Jason; et al. (2008). "Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation".
616: 438:, Gainer J & Grabiak R, "Bipolar trans carotenoid salts and their uses", issued 2011-04-05 96: 92: 100: 81: 164:, Gainer J, "New Class of Therapeutics that Enhance Small Molecule Diffusion", issued 2009-04-30 621: 478: 49: 435: 347: 161: 132:
through plasma via diffusion. Since blood plasma offers the major barrier for oxygen to move from the
45: 33: 25: 64:
One of the first substances that was reported to produce an oxygen diffusion-enhancing effect was
611: 351: 326: 212: 580: 557: 506: 390: 318: 282: 247: 204: 37: 547: 539: 466: 382: 310: 274: 239: 196: 21: 606: 78:. Saffron has been used culturally (e.g., as a dye) and medicinally since ancient times. 386: 552: 527: 133: 70: 600: 243: 128: 330: 216: 528:"Protection against focal ischemic injury to the brain by trans-sodium crocetinate" 314: 85: 29: 127:
forces that interact with water molecules. These interactions result in greater
278: 200: 124: 543: 187:
Gainer, J (2008). "Trans-sodium crocetinate for treating hypoxia/ischemia".
44:(a lack of oxygen in the circulating blood supply). Such conditions include 561: 394: 322: 286: 230:
Gainer J; G.M. Chisolm III (1974). "Oxygen diffusion and atherosclerosis".
208: 251: 104: 65: 41: 75: 470: 112: 108: 53: 123:
Oxygen diffusion-enhancing compounds are thought to act by exerting
20:
is any substance that increases the availability of oxygen in
68:, a carotenoid that occurs naturally in plants such as 342: 340: 496: 494: 452: 450: 8: 483:: CS1 maint: multiple names: authors list ( 182: 180: 178: 176: 551: 430: 428: 426: 156: 154: 152: 575:Starr, Cecie; McMillan, Beverly (2012). 459:Journal of the American Chemical Society 411:. Diffusion Pharmaceuticals. May 5, 2020 74:, and is related to another carotenoid, 189:Expert Opinion on Investigational Drugs 148: 88:, an aggressive form of brain cancer. 476: 99:is currently investigating the use of 505:. New York: Oxford University Press. 7: 32:and thereby promoting the movement ( 18:oxygen diffusion-enhancing compound 579:(9th ed.). Cengage Learning. 40:(a lack of oxygen in tissues) and 14: 91:TSC, which is being developed by 267:Cancer Detection and Prevention 526:Manabe H, et al. (2010). 315:10.1016/j.brainres.2009.10.067 1: 627:Drugs by mechanism of action 244:10.1016/0021-9150(74)90049-5 387:10.3171/JNS/2008/108/5/0972 643: 503:Pharmacology for Chemists 501:Cannon, Joseph G (1999). 279:10.1016/j.cdp.2004.09.002 201:10.1517/13543784.17.6.917 97:Diffusion Pharmaceuticals 93:Diffusion Pharmaceuticals 544:10.3171/2009.10.JNS09562 101:trans sodium crocetinate 82:Trans sodium crocetinate 532:Journal of Neurosurgery 375:Journal of Neurosurgery 436:US patent 7919527 162:US patent 8206751 50:myocardial infarction 103:in the treatment of 52:(heart attack), and 119:Mechanism of action 26:molecular structure 24:by influencing the 617:Chemical compounds 352:ClinicalTrials.gov 471:10.1021/ja981656j 465:(36): 9394–9395. 46:hemorrhagic shock 634: 591: 590: 572: 566: 565: 555: 523: 517: 516: 498: 489: 488: 482: 474: 454: 445: 444: 443: 439: 432: 421: 420: 418: 416: 405: 399: 398: 370: 364: 363: 361: 359: 344: 335: 334: 297: 291: 290: 262: 256: 255: 227: 221: 220: 184: 171: 170: 169: 165: 158: 129:hydrogen bonding 642: 641: 637: 636: 635: 633: 632: 631: 597: 596: 595: 594: 587: 574: 573: 569: 525: 524: 520: 513: 500: 499: 492: 475: 456: 455: 448: 441: 434: 433: 424: 414: 412: 407: 406: 402: 372: 371: 367: 357: 355: 354:. November 2011 346: 345: 338: 299: 298: 294: 264: 263: 259: 232:Atherosclerosis 229: 228: 224: 186: 185: 174: 167: 160: 159: 150: 145: 134:red blood cells 121: 62: 12: 11: 5: 640: 638: 630: 629: 624: 619: 614: 609: 599: 598: 593: 592: 586:978-0840061669 585: 567: 538:(4): 802–809. 518: 512:978-0841235243 511: 490: 446: 422: 400: 381:(5): 972–978. 365: 336: 303:Brain Research 292: 273:(6): 426–432. 257: 238:(1): 135–138. 222: 195:(6): 917–924. 172: 147: 146: 144: 141: 120: 117: 71:crocus sativus 61: 58: 13: 10: 9: 6: 4: 3: 2: 639: 628: 625: 623: 620: 618: 615: 613: 610: 608: 605: 604: 602: 588: 582: 578: 577:Human Biology 571: 568: 563: 559: 554: 549: 545: 541: 537: 533: 529: 522: 519: 514: 508: 504: 497: 495: 491: 486: 480: 472: 468: 464: 460: 453: 451: 447: 437: 431: 429: 427: 423: 410: 404: 401: 396: 392: 388: 384: 380: 376: 369: 366: 353: 349: 343: 341: 337: 332: 328: 324: 320: 316: 312: 308: 304: 296: 293: 288: 284: 280: 276: 272: 268: 261: 258: 253: 249: 245: 241: 237: 233: 226: 223: 218: 214: 210: 206: 202: 198: 194: 190: 183: 181: 179: 177: 173: 163: 157: 155: 153: 149: 142: 140: 137: 135: 130: 126: 118: 116: 114: 110: 106: 102: 98: 94: 89: 87: 83: 79: 77: 73: 72: 67: 59: 57: 55: 51: 47: 43: 39: 35: 31: 27: 23: 19: 622:Biochemistry 576: 570: 535: 531: 521: 502: 479:cite journal 462: 458: 413:. Retrieved 403: 378: 374: 368: 358:18 September 356:. Retrieved 306: 302: 295: 270: 266: 260: 235: 231: 225: 192: 188: 138: 122: 111:, and solid 90: 86:glioblastoma 80: 69: 63: 30:blood plasma 28:of water in 22:body tissues 17: 15: 309:: 136–145. 125:hydrophobic 601:Categories 143:References 612:Diffusion 113:cancerous 34:diffusion 562:19961314 395:18447715 331:25369069 323:19891959 287:15582266 217:71663644 209:18491992 115:tumors. 107:, acute 105:COVID-19 66:crocetin 42:ischemia 553:3380430 415:May 25, 252:4810465 76:saffron 38:hypoxia 607:Oxygen 583:  560:  550:  509:  442:  393:  329:  321:  285:  250:  215:  207:  168:  109:stroke 54:stroke 327:S2CID 213:S2CID 60:Types 581:ISBN 558:PMID 507:ISBN 485:link 417:2020 391:PMID 360:2012 319:PMID 307:1309 283:PMID 248:PMID 205:PMID 548:PMC 540:doi 536:113 467:doi 463:120 383:doi 379:108 311:doi 275:doi 240:doi 197:doi 16:An 603:: 556:. 546:. 534:. 530:. 493:^ 481:}} 477:{{ 461:. 449:^ 425:^ 389:. 377:. 350:. 339:^ 325:. 317:. 305:. 281:. 271:28 269:. 246:. 236:19 234:. 211:. 203:. 193:17 191:. 175:^ 151:^ 56:. 48:, 589:. 564:. 542:: 515:. 487:) 473:. 469:: 419:. 397:. 385:: 362:. 333:. 313:: 289:. 277:: 254:. 242:: 219:. 199::

Index

body tissues
molecular structure
blood plasma
diffusion
hypoxia
ischemia
hemorrhagic shock
myocardial infarction
stroke
crocetin
crocus sativus
saffron
Trans sodium crocetinate
glioblastoma
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
trans sodium crocetinate
COVID-19
stroke
cancerous
hydrophobic
hydrogen bonding
red blood cells



US patent 8206751


Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.